Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II Study of Growth Hormone in Children With Cystic Fibrosis

Trial Profile

Phase II Study of Growth Hormone in Children With Cystic Fibrosis

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Sep 2008

At a glance

  • Drugs Somatrogon (Primary)
  • Indications Growth disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Sep 2008 Actual completion date added from ClinicalTrials.gov.
    • 19 Feb 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top